Home Page 7

Future proof your compliance strategy

Leverage cutting-edge technology to provide timely regulatory updates, predictive analytics and automated workflows. Stay ahead of regulatory changes and ensure continuous compliance for sustained success.

Book a demo Industries we cover
Lifescience Banner 1
Lifescience Banner 2

Your Regulatory Solution

Challenge Green Icon

Challenge

Keeping up with frequent regulatory changes, such as FDA updates or EU directives, can lead to compliance gaps and inefficiencies in drug development and clinical trials.

3 Arrows Green Icon
Alerts Icon

Solution

RegAlerts enables you to stay ahead with timely, accurate, and actionable alerts. Receive instant notifications and in-depth analysis to manage drug development, clinical trials, and regulatory submissions proactively.

Explore RegAlerts
Challenge Green Icon

Challenge

Limited access to comprehensive and actionable compliance insights makes data-driven decision-making challenging, impacting R&D, and maintaining regulatory compliance.

3 Arrows Green Icon
Data Driven Excellence Icon

Solution

RegInsights unlocks augmented analytics that drive data-informed decisions for R&D and compliance. Optimized workflows and insights ensure regulatory adherence and research success.

Explore RegInsights
Challenge Green Icon

Challenge

Navigating complex regulatory environments can be difficult due to a lack of reliable and accurate information, increasing risks in drug approvals and market access.

3 Arrows Green Icon
AskRegASK Product Icon

Solution

Ask RegASK delivers precise and reliable answers to regulatory queries. Leverage over 1700+ regulatory experts, in over 157 markets to navigate complex environments with ease.

Explore Ask RegASK
Challenge Green Icon

Challenge

Integrating multiple compliance tools and processes into a cohesive system is challenging, often leading to inefficiencies and fragmented workflows.

3 Arrows Green Icon
Reggenius Product Icon (2)

Solution

RegGenius integrates multiple AI-Driven capabilities; a GenAI conversational platform, augmented analytics, content summarization and translations. Ensuring efficient management of regulatory submissions, quality compliance, and supply chain operations.

Explore RegGenius

Why RegASK

Why Regask

At RegASK we combine advanced machine learning algorithms with expertise of our regulatory professionals to deliver accurate actionable timely insights.

Leverage RegASK to identify and mitigate regulatory risks with advanced technologies, reducing errors and ensuring accuracy.

RegASK tailors regulatory insights to your specific needs, ensuring relevant and actionable information. Our platform adapts to businesses of all sizes, offering a comprehensive and dynamic approach to compliance management.

RegASK's cutting-edge platform features a powerful task management system that transforms regulatory workflows, empowering you to seamlessly manage every aspect of the regulatory process.

Stay ahead of compliance requirements with RegASK’s timely monitoring, enabling proactive identification of non-compliance issues and generating timely reports.

Cta 2 Strip
“RegASK provides us with customized, timely and actionable regulatory intelligence to ensure compliance with the dynamic global regulatory environment, and drive a competitive advantage for our business. We are pleased with our decision to partner with RegASK.”

Todd Chermak R.Ph., Ph.D.
GSVP and Global Business Head Immunology and Proteomics
CellCarta

Resources

UK MHRA Sets Regulatory Pathway to Phase Out Animal Tes…
On March 24, 2026, the Medicines & Healthcare products Regulatory Agency (MHRA) introduced new regulatory principles for human medicines…
Read more
Japan Updates JPMA Self-Inspection Checklist for Qualit…
On March 26, 2026, the Japan Pharmaceutical Manufacturers Association (JPMA) published a revised self-inspection checklist for quality tes…
Read more
EU PFAS Restrictions: ECHA Launches SEAC Consultation w…
On March 26, 2026, the European Chemicals Agency (ECHA) launched a public consultation on a draft opinion issued by the Committee for Socio-…
Read more
Brazil ANVISA Updates COVID-19 Vaccine Strains, Low-Ris…
On March 24, 2026, the Brazilian National Health Surveillance Agency (ANVISA) announced a set of regulatory updates impacting COVID-19 vacci…
Read more
Türkiye Updates Packaging and Patient Leaflet Rules fo…
The Turkish Medicines and Medical Devices Agency published substantial revisions to its guideline on package information and patient informa…
Read more
Netherlands MEB Introduces Declaration Requirement for …
On March 11, 2026, the Medicines Evaluation Board (MEB) in the Netherlands published new declaration guidance for applicants seeking Duplex …
Read more